CN107050352A - A kind of Chinese medicine composition for treating chronic hepatitis B - Google Patents
A kind of Chinese medicine composition for treating chronic hepatitis B Download PDFInfo
- Publication number
- CN107050352A CN107050352A CN201710133653.0A CN201710133653A CN107050352A CN 107050352 A CN107050352 A CN 107050352A CN 201710133653 A CN201710133653 A CN 201710133653A CN 107050352 A CN107050352 A CN 107050352A
- Authority
- CN
- China
- Prior art keywords
- parts
- chinese medicine
- medicine composition
- jiao
- extract
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 64
- 239000000203 mixture Substances 0.000 title claims abstract description 59
- 208000002672 hepatitis B Diseases 0.000 title claims abstract description 46
- 208000000419 Chronic Hepatitis B Diseases 0.000 title claims abstract description 26
- 235000013399 edible fruits Nutrition 0.000 claims abstract description 33
- 241001251068 Formica fusca Species 0.000 claims abstract description 21
- 239000009636 Huang Qi Substances 0.000 claims abstract description 18
- 240000006079 Schisandra chinensis Species 0.000 claims abstract description 17
- 241000132012 Atractylodes Species 0.000 claims abstract description 16
- 235000009917 Crataegus X brevipes Nutrition 0.000 claims abstract description 16
- 235000013204 Crataegus X haemacarpa Nutrition 0.000 claims abstract description 16
- 235000009685 Crataegus X maligna Nutrition 0.000 claims abstract description 16
- 235000009444 Crataegus X rubrocarnea Nutrition 0.000 claims abstract description 16
- 235000009486 Crataegus bullatus Nutrition 0.000 claims abstract description 16
- 235000017181 Crataegus chrysocarpa Nutrition 0.000 claims abstract description 16
- 235000009682 Crataegus limnophila Nutrition 0.000 claims abstract description 16
- 235000004423 Crataegus monogyna Nutrition 0.000 claims abstract description 16
- 235000002313 Crataegus paludosa Nutrition 0.000 claims abstract description 16
- 235000009840 Crataegus x incaedua Nutrition 0.000 claims abstract description 16
- 241000522190 Desmodium Species 0.000 claims abstract description 16
- 244000219416 Hypericum japonicum Species 0.000 claims abstract description 16
- 244000241872 Lycium chinense Species 0.000 claims abstract description 16
- 235000015468 Lycium chinense Nutrition 0.000 claims abstract description 16
- GXCLVBGFBYZDAG-UHFFFAOYSA-N N-[2-(1H-indol-3-yl)ethyl]-N-methylprop-2-en-1-amine Chemical compound CN(CCC1=CNC2=C1C=CC=C2)CC=C GXCLVBGFBYZDAG-UHFFFAOYSA-N 0.000 claims abstract description 16
- 241001248610 Ophiocordyceps sinensis Species 0.000 claims abstract description 16
- 240000001341 Reynoutria japonica Species 0.000 claims abstract description 16
- 235000018167 Reynoutria japonica Nutrition 0.000 claims abstract description 16
- 240000003152 Rhus chinensis Species 0.000 claims abstract description 16
- 235000014220 Rhus chinensis Nutrition 0.000 claims abstract description 16
- 241000270666 Testudines Species 0.000 claims abstract description 16
- 240000002503 Vitis amurensis Species 0.000 claims abstract description 15
- 239000011148 porous material Substances 0.000 claims abstract description 14
- 241000522620 Scorpio Species 0.000 claims abstract description 13
- 239000009490 scorpio Substances 0.000 claims abstract description 13
- 240000000171 Crataegus monogyna Species 0.000 claims abstract 5
- 239000000284 extract Substances 0.000 claims description 54
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 24
- 238000003756 stirring Methods 0.000 claims description 15
- 238000002360 preparation method Methods 0.000 claims description 12
- 240000005250 Chrysanthemum indicum Species 0.000 claims description 8
- 235000018959 Chrysanthemum indicum Nutrition 0.000 claims description 8
- 241000718543 Ormosia krugii Species 0.000 claims description 8
- 240000004980 Rheum officinale Species 0.000 claims description 8
- 235000008081 Rheum officinale Nutrition 0.000 claims description 8
- 239000002775 capsule Substances 0.000 claims description 6
- 238000001556 precipitation Methods 0.000 claims description 3
- 230000002829 reductive effect Effects 0.000 claims description 3
- 239000006228 supernatant Substances 0.000 claims description 3
- 239000000725 suspension Substances 0.000 claims description 3
- 235000015112 vegetable and seed oil Nutrition 0.000 claims description 3
- 239000008158 vegetable oil Substances 0.000 claims description 3
- 238000001035 drying Methods 0.000 claims description 2
- 244000126002 Ziziphus vulgaris Species 0.000 claims 3
- 241000219095 Vitis Species 0.000 claims 1
- 235000009754 Vitis X bourquina Nutrition 0.000 claims 1
- 235000012333 Vitis X labruscana Nutrition 0.000 claims 1
- 235000014787 Vitis vinifera Nutrition 0.000 claims 1
- 239000002245 particle Substances 0.000 claims 1
- 210000004185 liver Anatomy 0.000 abstract description 24
- 230000000694 effects Effects 0.000 abstract description 17
- 210000003734 kidney Anatomy 0.000 abstract description 10
- 238000005728 strengthening Methods 0.000 abstract description 7
- 231100000614 poison Toxicity 0.000 abstract description 6
- 239000002574 poison Substances 0.000 abstract description 5
- 108090000790 Enzymes Proteins 0.000 abstract description 4
- 102000004190 Enzymes Human genes 0.000 abstract description 4
- 241000721047 Danaus plexippus Species 0.000 abstract description 3
- 238000006243 chemical reaction Methods 0.000 abstract description 3
- 230000003612 virological effect Effects 0.000 abstract description 3
- 239000004480 active ingredient Substances 0.000 abstract description 2
- 239000011149 active material Substances 0.000 abstract description 2
- 230000002457 bidirectional effect Effects 0.000 abstract description 2
- 230000001717 pathogenic effect Effects 0.000 abstract description 2
- 231100000572 poisoning Toxicity 0.000 abstract description 2
- 230000000607 poisoning effect Effects 0.000 abstract description 2
- 239000002994 raw material Substances 0.000 abstract description 2
- 241001092040 Crataegus Species 0.000 description 11
- 208000006454 hepatitis Diseases 0.000 description 11
- 210000000952 spleen Anatomy 0.000 description 10
- 208000019423 liver disease Diseases 0.000 description 7
- 230000003908 liver function Effects 0.000 description 7
- 230000001737 promoting effect Effects 0.000 description 7
- 208000024891 symptom Diseases 0.000 description 7
- 241000700605 Viruses Species 0.000 description 6
- 229940079593 drug Drugs 0.000 description 6
- 241001247821 Ziziphus Species 0.000 description 5
- 230000001154 acute effect Effects 0.000 description 5
- 231100000283 hepatitis Toxicity 0.000 description 5
- 206010008909 Chronic Hepatitis Diseases 0.000 description 4
- 230000029087 digestion Effects 0.000 description 4
- 210000003205 muscle Anatomy 0.000 description 4
- 210000002784 stomach Anatomy 0.000 description 4
- 206010003445 Ascites Diseases 0.000 description 3
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 3
- 102000014150 Interferons Human genes 0.000 description 3
- 108010050904 Interferons Proteins 0.000 description 3
- 208000004880 Polyuria Diseases 0.000 description 3
- 241000239226 Scorpiones Species 0.000 description 3
- 230000033228 biological regulation Effects 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- 230000001684 chronic effect Effects 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 230000035619 diuresis Effects 0.000 description 3
- 230000002708 enhancing effect Effects 0.000 description 3
- 229940088598 enzyme Drugs 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 230000036737 immune function Effects 0.000 description 3
- 229940079322 interferon Drugs 0.000 description 3
- 210000004072 lung Anatomy 0.000 description 3
- 210000000130 stem cell Anatomy 0.000 description 3
- 206010061218 Inflammation Diseases 0.000 description 2
- 206010023126 Jaundice Diseases 0.000 description 2
- 206010037660 Pyrexia Diseases 0.000 description 2
- 208000034189 Sclerosis Diseases 0.000 description 2
- 241001251949 Xanthium sibiricum Species 0.000 description 2
- 239000000427 antigen Substances 0.000 description 2
- 102000036639 antigens Human genes 0.000 description 2
- 108091007433 antigens Proteins 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 230000004087 circulation Effects 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 230000002440 hepatic effect Effects 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- 238000007689 inspection Methods 0.000 description 2
- 201000007270 liver cancer Diseases 0.000 description 2
- 210000005229 liver cell Anatomy 0.000 description 2
- 208000014018 liver neoplasm Diseases 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 206010000060 Abdominal distension Diseases 0.000 description 1
- 108010082126 Alanine transaminase Proteins 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 229920002527 Glycogen Polymers 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 206010056522 Hepatic infection Diseases 0.000 description 1
- 208000005176 Hepatitis C Diseases 0.000 description 1
- 206010019799 Hepatitis viral Diseases 0.000 description 1
- 206010020741 Hyperpyrexia Diseases 0.000 description 1
- 206010062767 Hypophysitis Diseases 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 102000015696 Interleukins Human genes 0.000 description 1
- 108010063738 Interleukins Proteins 0.000 description 1
- 102000016943 Muramidase Human genes 0.000 description 1
- 108010014251 Muramidase Proteins 0.000 description 1
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 1
- 206010059013 Nocturnal emission Diseases 0.000 description 1
- 208000002193 Pain Diseases 0.000 description 1
- 206010057249 Phagocytosis Diseases 0.000 description 1
- 101710098398 Probable alanine aminotransferase, mitochondrial Proteins 0.000 description 1
- 206010057190 Respiratory tract infections Diseases 0.000 description 1
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 1
- 241000238370 Sepia Species 0.000 description 1
- PJANXHGTPQOBST-VAWYXSNFSA-N Stilbene Natural products C=1C=CC=CC=1/C=C/C1=CC=CC=C1 PJANXHGTPQOBST-VAWYXSNFSA-N 0.000 description 1
- 210000001744 T-lymphocyte Anatomy 0.000 description 1
- 208000010183 Thymus Hyperplasia Diseases 0.000 description 1
- 238000008050 Total Bilirubin Reagent Methods 0.000 description 1
- 206010046306 Upper respiratory tract infection Diseases 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 208000022531 anorexia Diseases 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 230000006399 behavior Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000000157 blood function Effects 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 230000007969 cellular immunity Effects 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 206010061428 decreased appetite Diseases 0.000 description 1
- 238000001784 detoxification Methods 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 230000001882 diuretic effect Effects 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 229940096919 glycogen Drugs 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 206010019847 hepatosplenomegaly Diseases 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 229940047122 interleukins Drugs 0.000 description 1
- 230000002147 killing effect Effects 0.000 description 1
- 230000005976 liver dysfunction Effects 0.000 description 1
- 238000007449 liver function test Methods 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 210000001165 lymph node Anatomy 0.000 description 1
- 229960000274 lysozyme Drugs 0.000 description 1
- 235000010335 lysozyme Nutrition 0.000 description 1
- 239000004325 lysozyme Substances 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000002558 medical inspection Methods 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 210000000865 mononuclear phagocyte system Anatomy 0.000 description 1
- 210000000653 nervous system Anatomy 0.000 description 1
- 230000000242 pagocytic effect Effects 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- 230000008782 phagocytosis Effects 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 208000037821 progressive disease Diseases 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 208000020029 respiratory tract infectious disease Diseases 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 239000011669 selenium Substances 0.000 description 1
- 229910052711 selenium Inorganic materials 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- PJANXHGTPQOBST-UHFFFAOYSA-N stilbene Chemical compound C=1C=CC=CC=1C=CC1=CC=CC=C1 PJANXHGTPQOBST-UHFFFAOYSA-N 0.000 description 1
- 235000021286 stilbenes Nutrition 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 230000029812 viral genome replication Effects 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/58—Reptiles
- A61K35/586—Turtles; Tortoises, e.g. terrapins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
- A61K35/646—Arachnids, e.g. spiders, scorpions, ticks or mites
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/062—Ascomycota
- A61K36/066—Clavicipitaceae
- A61K36/068—Cordyceps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/284—Atractylodes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/287—Chrysanthemum, e.g. daisy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/38—Clusiaceae, Hypericaceae or Guttiferae (Hypericum or Mangosteen family), e.g. common St. Johnswort
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/481—Astragalus (milkvetch)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/51—Gentianaceae (Gentian family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/57—Magnoliaceae (Magnolia family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
- A61K36/704—Polygonum, e.g. knotweed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
- A61K36/708—Rheum (rhubarb)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/72—Rhamnaceae (Buckthorn family), e.g. buckthorn, chewstick or umbrella-tree
- A61K36/725—Ziziphus, e.g. jujube
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/734—Crataegus (hawthorn)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/752—Citrus, e.g. lime, orange or lemon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/79—Schisandraceae (Schisandra family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
- A61K36/815—Lycium (desert-thorn)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/87—Vitaceae or Ampelidaceae (Vine or Grape family), e.g. wine grapes, muscadine or peppervine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
- A61K36/8998—Hordeum (barley)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/53—Liquid-solid separation, e.g. centrifugation, sedimentation or crystallization
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Engineering & Computer Science (AREA)
- Insects & Arthropods (AREA)
- Tropical Medicine & Parasitology (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The present invention discloses a kind of Chinese medicine composition for treating chronic hepatitis B.The present composition is by following parts by weight meter, 50 parts of silky ant, 3 parts of scorpio, 25 parts of turtle shell, 35 parts of the bighead atractylodes rhizome, 45 parts of cordyceps sinensis, 30 parts of the fruit of Chinese wolfberry, 5 parts of the Radix Astragali, 20 parts of the fruit of Chinese magnoliavine, 0.5 part of bark of ash, 45 parts of umbellate pore furgus, 30 parts of dried orange peel, 30 parts of hawthorn (Jiao), 30 parts of Medicated Leaven (Jiao), 30 parts of malt (Jiao), 30 parts of rascal, 45 parts of nutgall, 45 parts of the fleece-flower root, 45 parts of V. amurensis, 45 parts of hypericum japonicum, 45 parts of desmodium.The present invention gives full play to the distinctive broad immune bidirectional modulation of ant, remaining the whole active ingredients of ant raw material and active material simultaneously, utilization is directly being absorbed by organisms in the form of enzyme, using silky ant as monarch, this medicine is clearing heat and detoxicating, run through with poisoning poison, catch the viral characteristic of chronic hepatitis B, the Radix Astragali is minister, there is nourishing liver and kidney, clearing heat and detoxicating, soothing the liver protect liver, strengthening vital QI to eliminate pathogenic factors, curative effect is stable, and negative conversion rate, cure rate are high, the characteristics of recurrence rate is low.
Description
Technical field
The present invention relates to a kind of Chinese medicine composition, belong to the medicine for the treatment of hepatopathy, specifically one kind treats chronic
The Chinese medicine composition of type hepatitis.
Background technology
Hepatitis B is a kind of communicable disease, and WHO is counted, and it is chronic that the whole world there are about 2.4 hundred million trouble（For a long time）Hepatic infection
Disease, every year about 780,000 people die from acute or chronic hepatitis.
Illness rate highest is virus hepatitis in China's liver diseases, wherein with the illness rate highest of hepatitis B, entirely
1-59 Sui crowd's hepatitis B of state carries ratio 7%.According to incompletely statistics, the existing Patients with Hepatitis B Virus Infection of China more than 100,000,000, chronic
The people of hepatopathy people more than 2,000 ten thousand, is the district occurred frequently of hepatitis B.The serious diseases such as the existing hepatic sclerosis of China, liver cancer, be all more than 80% by
Hepatitis B is developed.Chronic hepatitis based on hepatitis B and hepatitis C, is that current influence our people lives and caused
The serious progressive disease of related economic, social concern, especially hepatitis B.
It has been the very urgent task currently faced to protect liver health.But it is up to the present, existing to control
It is to kill virus indirectly while antibody is increased to treat viral medicine such as interferon, and negative conversion rate is low, and easily recurrence.
The content of the invention
It is an object of the invention to provide a kind of Chinese medicine composition for treating chronic hepatitis B, with invigorating Qi and tonifying kidney, promoting blood circulation
Nourishing the liver, the stagnant dampness elimination of row.
To achieve the above object, a kind of Chinese medicine composition for treating chronic hepatitis B of the present invention, the composition
By following parts by weight meter, 40-50 parts of silky ant, 2-3 parts of scorpio, 20-25 parts of turtle shell, 0.5-35 parts of the bighead atractylodes rhizome, cordyceps sinensis 0.5-45
Part, 5-30 parts of the fruit of Chinese wolfberry, 5-30 parts of the Radix Astragali, 20-25 parts of the fruit of Chinese magnoliavine, 0.5-35 parts of bark of ash, 0.5-45 parts of umbellate pore furgus, dried orange peel 5-30
Part, 5-30 parts of hawthorn (Jiao), 5-30 parts of Medicated Leaven (Jiao), 5-30 parts of malt (Jiao), 5-30 parts of rascal, 0.5-45 parts of nutgall,
0.5-45 parts of the fleece-flower root, 0.5-45 parts of V. amurensis, 0.5-45 parts of hypericum japonicum, 0.5-45 parts of desmodium.
A kind of Chinese medicine composition for treating chronic hepatitis B, it is characterised in that：The composition is by following weight
Number meter, 45-50 parts of silky ant, 3 parts of scorpio, 25 parts of turtle shell, 35 parts of the bighead atractylodes rhizome, 45 parts of cordyceps sinensis, 30 parts of the fruit of Chinese wolfberry, 30 parts of the Radix Astragali,
25 parts of the fruit of Chinese magnoliavine, 20-35 parts of bark of ash, 30-45 parts of umbellate pore furgus, 5 parts of dried orange peel, 5 parts of hawthorn (Jiao), 5-10 parts of Medicated Leaven (Jiao), malt
5-10 parts of (Jiao), 5-10 parts of rascal, 0.5-15 parts of nutgall, 0.5-15 parts of the fleece-flower root, 0.5-15 parts of V. amurensis, hypericum japonicum 0.5-
5 parts, 0.5-5 parts of desmodium.
A kind of Chinese medicine composition for treating chronic hepatitis B, it is characterised in that：The composition is by following weight
Number meter, in addition to 0.5-5 parts of rheum officinale, 0.5-5 parts of Canton love-pea vine, 0.5-5 parts of jujube, 0.5-5 parts of chrysanthemum indicum.
A kind of Chinese medicine composition for treating chronic hepatitis B, it is characterised in that：The composition is by following weight
Number meter, in addition to 3-5 parts of rheum officinale, 3-5 parts of Canton love-pea vine, 1-5 parts of jujube, 4.5-5 parts of chrysanthemum indicum.
A kind of preparation method for treating chronic hepatitis B Chinese medicine composition, realizes that step is as follows：
（1）Extract silky ant, scorpio, turtle shell extract it is standby, take the bighead atractylodes rhizome, cordyceps sinensis, the fruit of Chinese wolfberry, the Radix Astragali, the fruit of Chinese magnoliavine, bark of ash,
Medicinal extract is made after umbellate pore furgus, dried orange peel, hawthorn (Jiao), Medicated Leaven (Jiao), malt (Jiao), rascal decoction at a temperature of 20-40 DEG C standby,
Nutgall, the fleece-flower root, V. amurensis, hypericum japonicum, desmodium are decocted into 30-60min and obtain decoction liquor；
（2）Described extract, medicinal extract, decoction liquor stirring are mixed to get Chinese medicine composition.
A kind of preparation method for treating chronic hepatitis B Chinese medicine composition, realizes that step is as follows：
（1）Extract silky ant, scorpio, turtle shell extract it is standby, take the bighead atractylodes rhizome, cordyceps sinensis, the fruit of Chinese wolfberry, the Radix Astragali, the fruit of Chinese magnoliavine, bark of ash,
Medicinal extract is made after umbellate pore furgus, dried orange peel, hawthorn (Jiao), Medicated Leaven (Jiao), malt (Jiao), rascal decoction at a temperature of 20-40 DEG C standby,
Nutgall, the fleece-flower root, V. amurensis, hypericum japonicum, desmodium, rheum officinale, Canton love-pea vine, jujube, chrysanthemum indicum are decocted 30-60min and obtained
Decoction liquor；
（2）Described extract, medicinal extract, decoction liquor stirring are mixed to get Chinese medicine composition.
Described extract, medicinal extract, decoction liquor stirring are mixed to get Chinese medicine composition and add the ethanol that volumetric concentration is 90-98%
It is 60% to concentration of alcohol, places be no less than 12h at room temperature, suction out supernatant, centrifuge alcohol precipitation suspension, merge ethanol solution, subtract
Push back after receipts ethanol, be concentrated into 60 DEG C of relative density 1.10-1.14, dry and be made.
Described extract, medicinal extract, decoction liquor stirring are mixed to get Chinese medicine composition and extract drying are made, and are made
Grain, is distributed into packed electuary.
Described extract, medicinal extract, decoction liquor stirring, which are mixed to get after Chinese medicine composition is dried, is pressed into tablet.
Described extract, medicinal extract, decoction liquor stirring are mixed to get Chinese medicine composition plus vegetable oil loads capsule, is made
Capsule.
In the liver disease drug of the present invention, effect of each taste Chinese medicine used and effect：
The silky ant formaldehyde containing cursive script, can resist hepatitis viruse, and regulation is immune, and liver protecting, turtle shell can reverse liver fine
Dimensionization, scorpio is combatted poison with poison, with the big poison of mild toxicity system, and full side is verified through many cases patient, forms antibody mostly, all treatment is effective；
But acute stage, is unavailable, acute stage based on clearing heat, detoxicating, dispelling dampness, when remission rear is available；In side silky ant color it is black enter
Kidney, sour enter liver, the effect with very strong enhancing immunologic function.Silky ant powerful fill blood function and two-way immunological regulation
Effect, can activate myeloid-lymphoid stem cell gene, stem cell is immunized in regulation marrow and candidate stem cell repairs liver cell；It can also supplement
Liver is protected in the trace elements such as zinc, selenium, calcium, nourishing the liver and kidney.Silky ant is monarch；Radix Astragali QI invigorating tonifying spleen, be abide by Zhong Jing " see liver it
The purport of disease, in the ban real spleen ", therefore using it as minister.Other drug matching applications, play comprehensively regulating to treat the purpose of hepatopathy, and
Long-term use without side effects.
The bighead atractylodes rhizome has tonifying spleen, QI invigorating, dehumidifying, salubrity effect.
Cordyceps sinensis has secret lean gas, invigorates the lung and the kidney, hemostasis and phlegm effect.The phagocytosis of spleen and liver inner cell can be promoted
Function, plays the role of significantly to improve reticuloendothelial system phagocytic function in body
The fruit of Chinese wolfberry, with tonifying the liver and kidney, nourishing blood for improving eyesight effect.Pharmacological research shows：The medicine can promote liver cell newborn, prevent
Liver dysfunction.
The Radix Astragali, with invigorating qi for strengthening superficies, diuretic and maintain drug, tonifying middle-Jiao and Qi effect.The hepatitis reduced to cellular immune function
People, can strengthen cellular immunity, improve liver function.
The fruit of Chinese magnoliavine, to chronic hepatitis, patient plays the role of glutamate pyruvate transaminase lowering serum；Have to liver protein and Glycogen synthesis
Facilitation, and have inducing action to drug metabolic enzyme.Function of detoxification is improved, there is certain suppression to Immune Function
Effect.It is observed that to some patients with hepatosplenomegaly, having different degrees of retraction after oral fruit of Chinese magnoliavine preparation.
Bark of ash anti-inflammatory, by nervous system with exciting hypophysis, promotes cortex hormone of aadrenaline secretion increase and realizes it and resist
Inflammation effect.
Umbellate pore furgus, it is clearing damp and promoting diuresis, antitumor.
In dried orange peel strengthening the spleen and stomach, the tune that helps digestion.
In hawthorn (Jiao) strengthening the spleen and stomach, the tune that helps digestion.
In Medicated Leaven (Jiao) strengthening the spleen and stomach, the tune that helps digestion.
Malt (Jiao), with promoting the circulation of qi helps digestion, strengthening the spleen and stomach, soothing the liver promoting the circulation of qi effect.
Nutgall solid and gas, it is strong cloudy supporing yang, astringe the lung.
The fleece-flower root, nourishing the blood and yin, temperature bitter and puckery flavor, bitter kidney tonifying, temperature compensation liver can restrain essence so can the beneficial liver of blood-nourishing, controlling nocturnal emission with astringent drugs
Kidney-nourishing.
V. amurensis is mild-natured, sweet acid, enters lung, spleen, kidney channel, fills blood, liver and kidney benefiting.
Hypericum japonicum, clearing heat and promoting diuresis, subdhing swelling and detoxicating has excellent curative effect to catarrhal jaundice.
Desmodium, reducing fever and causing diuresis, wind-expelling pain-stopping, hemostasia and promoting granulation, eliminating inflammation and expelling toxin, the work(of desinsection, treating acute and chronic hepatitis, jaundice
Type hepatitis.
The duplication of rheum officinale, Canton love-pea vine, jujube, chrysanthemum indicum to hepatitis B all has certain inhibitory action, passes through enhancing
Then immunity of organisms removes hepatitis B by the immunity of body.
The present invention is using silky ant as monarch, and this medicine is clearing heat and detoxicating, is run through with poisoning poison, catches the viral characteristic of chronic hepatitis B, yellow
Stilbene is minister, and medicine is added and subtracted on square foundation, has fully demonstrated tcm treatment according to syndrome differentiation, and traditional Chinese medicinal components synergy is sufficiently catalytic each
The drug effect of position medicinal material.
A kind of Chinese medicine composition for treating chronic hepatitis B of the present invention, its advantage is：Give full play to ant
The distinctive broad immune bidirectional modulation of ant, is remaining the whole active ingredients of ant raw material and active material simultaneously, with the shape of enzyme
Formula is directly absorbed by organisms utilization, absorption rate is brought up to more than 80% from 20%, promote rudimentary thymic hyperplasia,
Weight increase, outstanding behaviours produces a large amount of interferon to induce itself, makes leucocyte, T lymphocytes and lysozyme increase, bright
The activity of aobvious enhancing interleukins II NKT virus, plays a part of killing hepatitis viruse and suppressing virus replication, by
In enzyme melt virus, on the premise of cell is not killed, virus is dissolved in extracellular, cell is protected, with it is nourishing liver and kidney,
Clearing heat and detoxicating, soothing the liver protect liver, effect of strengthening vital QI to eliminate pathogenic factors, curative effect are stable, and negative conversion rate, cure rate are high, the characteristics of recurrence rate is low, simultaneously
It is also effective to hepatic sclerosis, ascites, liver cancer.
Embodiment
Embodiment 1
A kind of Chinese medicine composition for treating chronic hepatitis B, the composition is 50 parts of silky ant, complete by following parts by weight meter
3 parts of scorpion, 25 parts of turtle shell, 35 parts of the bighead atractylodes rhizome, 45 parts of cordyceps sinensis, 30 parts of the fruit of Chinese wolfberry, 5 parts of the Radix Astragali, 20 parts of the fruit of Chinese magnoliavine, 0.5 part of bark of ash, pig
45 parts of Siberian cocklebur, 30 parts of dried orange peel, 30 parts of hawthorn (Jiao), 30 parts of Medicated Leaven (Jiao), 30 parts of malt (Jiao), 30 parts of rascal, 45 parts of nutgall,
45 parts of the fleece-flower root, 45 parts of V. amurensis, 45 parts of hypericum japonicum, 45 parts of desmodium, the preparation method of Chinese medicine composition of the present invention are real
Existing step is as follows：
（1）Extract silky ant, scorpio, turtle shell extract it is standby, take the bighead atractylodes rhizome, cordyceps sinensis, the fruit of Chinese wolfberry, the Radix Astragali, the fruit of Chinese magnoliavine, bark of ash,
Medicinal extract is made after umbellate pore furgus, dried orange peel, hawthorn (Jiao), Medicated Leaven (Jiao), malt (Jiao), rascal decoction at a temperature of 40 DEG C standby, will
Nutgall, the fleece-flower root, V. amurensis, hypericum japonicum, desmodium decoct 60min and obtain decoction liquor；
（2）Described extract, medicinal extract, decoction liquor stirring are mixed to get Chinese medicine composition, the second that volumetric concentration is 98% is added
Alcohol to concentration of alcohol is 60%, places be no less than 12h at room temperature, suction out supernatant, centrifuge alcohol precipitation suspension, merge ethanol solution,
It is recovered under reduced pressure after ethanol, is concentrated into 60 DEG C of relative density 1.10-1.14, dries and be made.
The medicine of the present invention, sepia, gas micro-perfume, taste micro-sweet, slightly sour, free from extraneous odour, for oral, with warm water delivery service, often
Day 3 times, each 10-30mg 3 months is a course for the treatment of.
Embodiment 2
A kind of Chinese medicine composition for treating chronic hepatitis B, the composition is 45 parts of silky ant, complete by following parts by weight meter
3 parts of scorpion, 25 parts of turtle shell, 35 parts of the bighead atractylodes rhizome, 45 parts of cordyceps sinensis, 30 parts of the fruit of Chinese wolfberry, 30 parts of the Radix Astragali, 25 parts of the fruit of Chinese magnoliavine, 20-35 parts of bark of ash,
30-45 parts of umbellate pore furgus, 5 parts of dried orange peel, 5 parts of hawthorn (Jiao), 5 parts of Medicated Leaven (Jiao), 5 parts of malt (Jiao), 5 parts of rascal, nutgall 0.5
Part, 0.5 part of the fleece-flower root, 0.5- parts of V. amurensis, 0.5 part of hypericum japonicum, 0.5 part of desmodium, 5 parts of rheum officinale, 5 parts of Canton love-pea vine, jujube 5
Part, 5 parts of chrysanthemum indicum；Its preparation method, realizes that step is as follows：
（1）Extract silky ant, scorpio, turtle shell extract it is standby, take the bighead atractylodes rhizome, cordyceps sinensis, the fruit of Chinese wolfberry, the Radix Astragali, the fruit of Chinese magnoliavine, bark of ash,
Medicinal extract is made after umbellate pore furgus, dried orange peel, hawthorn (Jiao), Medicated Leaven (Jiao), malt (Jiao), rascal decoction at a temperature of 25 DEG C standby, will
Nutgall, the fleece-flower root, V. amurensis, hypericum japonicum, desmodium decoct 40min and obtain decoction liquor；
（2）Described extract, medicinal extract, decoction liquor stirring are mixed to get Chinese medicine composition extract is made and dried, is made
Grain, is distributed into packed electuary.
Embodiment 3
A kind of Chinese medicine composition for treating chronic hepatitis B, the composition is 50 parts of silky ant, complete by following parts by weight meter
3 parts of scorpion, 25 parts of turtle shell, 35 parts of the bighead atractylodes rhizome, 45 parts of cordyceps sinensis, 30 parts of the fruit of Chinese wolfberry, 30 parts of the Radix Astragali, 25 parts of the fruit of Chinese magnoliavine, 35 parts of bark of ash, pig
45 parts of Siberian cocklebur, 5 parts of dried orange peel, 5 parts of hawthorn (Jiao), 5-10 parts of Medicated Leaven (Jiao), 10 parts of malt (Jiao), 10 parts of rascal, 15 parts of nutgall,
0.5 part of the fleece-flower root, 0.5 part of V. amurensis, 0.5 part of hypericum japonicum, 0.5 part of desmodium；Its preparation method, realizes that step is as follows：
（1）Extract silky ant, scorpio, turtle shell extract it is standby, take the bighead atractylodes rhizome, cordyceps sinensis, the fruit of Chinese wolfberry, the Radix Astragali, the fruit of Chinese magnoliavine, bark of ash,
Medicinal extract is made after umbellate pore furgus, dried orange peel, hawthorn (Jiao), Medicated Leaven (Jiao), malt (Jiao), rascal decoction at a temperature of 20-40 DEG C standby,
Nutgall, the fleece-flower root, V. amurensis, hypericum japonicum, desmodium are decocted into 30-60min and obtain decoction liquor；
（2）Described extract, medicinal extract, decoction liquor stirring are mixed to get Chinese medicine composition plus vegetable oil loads capsule, is made
Capsule.
Case is selected：
1st, journey, female 28 years old, has hepatitis B " great three positive ", at the beginning of 5 months 2014, starts to take this medicament during pre-marital medical check-up, reported according to examining
Accuse single prompting：Surface antigen, e antigens, cAg are the positive, and liver function is normal.Without felling ailments oneself, diet, daily life
It is as usual, have rosy cheeks, tongue nature, tongue fur, pulse condition are intended, with righting, removing toxic substances, promoting blood circulation, soothing the liver method, using medicine bolus for hepatitis B also without abnormality discovery
Give clothes.
2nd, Wei, female, 34 years old, Cantonese, hepatitis B.Patient is super in local hospital B in June, 2012
Check, liver surface is uneven, liver volume reduces.Liver function test, SGPT 560U/L, total bilirubin 58ummol/L,
" two pair half " checks to be " great three positive " to hepatitis B.In August, 2013, Chinese medicine composition of the present invention is taken, at the beginning of 3 months 2015
To local hospital inspection, normally, " two pair half " checks negative to hepatitis B to liver function.
3rd, Zhang, man, 48 years old, Gansu can peaceful people.Patient starts for 30 years old, physical examination find " "small three positive" ", at that time body without
Any discomfort feels that spirit and muscle power are all fine, but to after 40 years old, often flu, and diarrhoea, spirit and muscle power are gradually poor, 2015
Year by the end of January, starts to take Chinese medicine composition of the present invention, taken after two weeks, and symptom starts to mitigate, after three months, spirit and muscle power
Return to normal, can be competent.Checked at the beginning of 1 month 2017, liver function is normal, hepatitis B two and half is negative.
4th, most certain, female, 35 years old, people from Hunan, HBV carrier 15 years.Occasionally there is urine yellow, the symptom such as anorexia, without too
It is more uncomfortable.Hepatitis B two and half is looked at 28 years old for " great three positive "." interferon " antiviral Western medicine of used long period, but symptom
All do not taken a turn for the better significantly with laboratory indexes.In by the end of May, 2013, starts to take Chinese medicine composition of the present invention, the end of the year in 2016, multiple
Liver function and hepatitis B two and half are looked into, inspection result, liver function is normal, " two pair of half " Section 2 and Section 5 are positive for hepatitis B.
5th, palace, man, 29 years old, people from Chongqing, before patient takes liver disease drug 20 days, because of hyperpyrexia, headache, pharyngalgia, in locality
Hospital admission, is diagnosed as acute upper respiratory infection, gives and brings down a fever and anti symptom treatment, and retroperitoneal lymph node increases increase.2013
On May 21, in starts, Chinese medicine composition of the present invention, after five days, and ascites starts to disappear, and after 12 months, ascites disappears substantially,
Spleen is started zooming out, and symptom improves.Continue to take to 3 months 2015 bottom various symptoms and disappear, medical inspection indices base
This is normal, and things are as usual for patient's life.
6th, Dong so-and-so, man, 46 years old, people from Chongqing, patient started for 27 years old, physical examination find " "small three positive" ", frequent abdominal distension abdomen
Rush down, work also feels painstaking.In by the end of January, 2010, starts to take Chinese medicine composition of the present invention, takes after January, and symptom starts to mitigate,
After three months, spirit and muscle power are returned to normal, can be competent.Checked at the beginning of 7 months 2012, liver function is normal, hepatitis B two
It is half-and-half negative.
Claims (10)
1. a kind of Chinese medicine composition for treating chronic hepatitis B, it is characterised in that：The composition by following parts by weight meter,
40-50 parts of silky ant, 2-3 parts of scorpio, 20-25 parts of turtle shell, 0.5-35 parts of the bighead atractylodes rhizome, 0.5-45 parts of cordyceps sinensis, 5-30 parts of the fruit of Chinese wolfberry,
5-30 parts of the Radix Astragali, 20-25 parts of the fruit of Chinese magnoliavine, 0.5-35 parts of bark of ash, 0.5-45 parts of umbellate pore furgus, 5-30 parts of dried orange peel, 5-30 parts of hawthorn (Jiao),
5-30 parts of Medicated Leaven (Jiao), 5-30 parts of malt (Jiao), 5-30 parts of rascal, 0.5-45 parts of nutgall, 0.5-45 parts of the fleece-flower root, mountain Portugal
0.5-45 parts of grape, 0.5-45 parts of hypericum japonicum, 0.5-45 parts of desmodium.
2. a kind of Chinese medicine composition for treating chronic hepatitis B as claimed in claim 1, it is characterised in that：The composition by
Following parts by weight meter, 45-50 parts of silky ant, 3 parts of scorpio, 25 parts of turtle shell, 35 parts of the bighead atractylodes rhizome, 45 parts of cordyceps sinensis, 30 parts of the fruit of Chinese wolfberry,
30 parts of the Radix Astragali, 25 parts of the fruit of Chinese magnoliavine, 20-35 parts of bark of ash, 30-45 parts of umbellate pore furgus, 5 parts of dried orange peel, 5 parts of hawthorn (Jiao), Medicated Leaven (Jiao) 5-
10 parts, 5-10 parts of malt (Jiao), 5-10 parts of rascal, 0.5-15 parts of nutgall, 0.5-15 parts of the fleece-flower root, 0.5-15 parts of V. amurensis,
0.5-5 parts of hypericum japonicum, 0.5-5 parts of desmodium.
3. a kind of Chinese medicine composition for treating chronic hepatitis B as claimed in claim 2, it is characterised in that：The composition by
Following parts by weight meter, in addition to 0.5-5 parts of rheum officinale, 0.5-5 parts of Canton love-pea vine, 0.5-5 parts of jujube, 0.5-5 parts of chrysanthemum indicum.
4. a kind of Chinese medicine composition for treating chronic hepatitis B as claimed in claim 3, it is characterised in that：The composition by
Following parts by weight meter, in addition to 3-5 parts of rheum officinale, 3-5 parts of Canton love-pea vine, 1-5 parts of jujube, 4.5-5 parts of chrysanthemum indicum.
5. a kind of preparation method for treating chronic hepatitis B Chinese medicine composition as claimed in claim 3, it is characterised in that：Realize
Step is as follows：
（1）Extract silky ant, scorpio, turtle shell extract it is standby, take the bighead atractylodes rhizome, cordyceps sinensis, the fruit of Chinese wolfberry, the Radix Astragali, the fruit of Chinese magnoliavine, bark of ash,
Medicinal extract is made after umbellate pore furgus, dried orange peel, hawthorn (Jiao), Medicated Leaven (Jiao), malt (Jiao), rascal decoction at a temperature of 20-40 DEG C standby,
Nutgall, the fleece-flower root, V. amurensis, hypericum japonicum, desmodium are decocted into 30-60min and obtain decoction liquor；
（2）Described extract, medicinal extract, decoction liquor stirring are mixed to get Chinese medicine composition.
6. a kind of preparation method for treating chronic hepatitis B Chinese medicine composition as claimed in claim 4, it is characterised in that：Realize
Step is as follows：
（1）Extract silky ant, scorpio, turtle shell extract it is standby, take the bighead atractylodes rhizome, cordyceps sinensis, the fruit of Chinese wolfberry, the Radix Astragali, the fruit of Chinese magnoliavine, bark of ash,
Medicinal extract is made after umbellate pore furgus, dried orange peel, hawthorn (Jiao), Medicated Leaven (Jiao), malt (Jiao), rascal decoction at a temperature of 20-40 DEG C standby,
Nutgall, the fleece-flower root, V. amurensis, hypericum japonicum, desmodium, rheum officinale, Canton love-pea vine, jujube, chrysanthemum indicum are decocted 30-60min and obtained
Decoction liquor；
（2）Described extract, medicinal extract, decoction liquor stirring are mixed to get Chinese medicine composition.
7. a kind of preparation method for treating chronic hepatitis B Chinese medicine composition as claimed in claim 6, it is characterised in that：By institute
The extract stated, medicinal extract, decoction liquor stirring are mixed to get Chinese medicine composition and add ethanol of the volumetric concentration for 90-98% to ethanol
Concentration is 60%, places be no less than 12h at room temperature, suction out supernatant, centrifuge alcohol precipitation suspension, merge ethanol solution, be recovered under reduced pressure
After ethanol, 60 DEG C of relative density 1.10-1.14 are concentrated into, dries and is made.
8. a kind of preparation method for treating chronic hepatitis B Chinese medicine composition as claimed in claim 6, it is characterised in that：By institute
The extract stated, medicinal extract, decoction liquor stirring are mixed to get Chinese medicine composition and extract drying are made, and particle is made, bag is distributed into
Fill electuary.
9. a kind of preparation method for treating chronic hepatitis B Chinese medicine composition as claimed in claim 6, it is characterised in that：By institute
The extract stated, medicinal extract, decoction liquor stirring, which are mixed to get after Chinese medicine composition is dried, is pressed into tablet.
10. a kind of preparation method for treating chronic hepatitis B Chinese medicine composition as claimed in claim 6, it is characterised in that：Will
Described extract, medicinal extract, decoction liquor stirring is mixed to get Chinese medicine composition plus vegetable oil loads capsule, and capsule is made.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201710133653.0A CN107050352A (en) | 2017-03-08 | 2017-03-08 | A kind of Chinese medicine composition for treating chronic hepatitis B |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201710133653.0A CN107050352A (en) | 2017-03-08 | 2017-03-08 | A kind of Chinese medicine composition for treating chronic hepatitis B |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN107050352A true CN107050352A (en) | 2017-08-18 |
Family
ID=59622079
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201710133653.0A Pending CN107050352A (en) | 2017-03-08 | 2017-03-08 | A kind of Chinese medicine composition for treating chronic hepatitis B |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN107050352A (en) |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1336233A (en) * | 2001-08-28 | 2002-02-20 | 王旭中 | Hepatitis B treating medicine |
| WO2012016429A1 (en) * | 2010-08-03 | 2012-02-09 | Asia Hepato Gene Co. | Compositions and methods for treating hepatitis virus infection |
| CN103223131A (en) * | 2013-05-13 | 2013-07-31 | 殷广全 | Liver disease drug |
| CN104815049A (en) * | 2015-04-30 | 2015-08-05 | 邓鑫 | Compound preparation prepared from natural taurine for treating chronic liver diseases and preparation method thereof |
-
2017
- 2017-03-08 CN CN201710133653.0A patent/CN107050352A/en active Pending
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1336233A (en) * | 2001-08-28 | 2002-02-20 | 王旭中 | Hepatitis B treating medicine |
| WO2012016429A1 (en) * | 2010-08-03 | 2012-02-09 | Asia Hepato Gene Co. | Compositions and methods for treating hepatitis virus infection |
| CN103223131A (en) * | 2013-05-13 | 2013-07-31 | 殷广全 | Liver disease drug |
| CN104815049A (en) * | 2015-04-30 | 2015-08-05 | 邓鑫 | Compound preparation prepared from natural taurine for treating chronic liver diseases and preparation method thereof |
Non-Patent Citations (1)
| Title |
|---|
| 陈宏义等: "中草药及复方抗乙肝病毒s、e抗原的研究与疗效", 《现代诊断与治疗》 * |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102205107B (en) | Chinese medicinal preparation for treating duodenal ulcer and preparation method thereof | |
| CN103495040B (en) | Traditional Chinese medicine composition for treating reflux esophagitis and preparation method of granule formulation thereof | |
| CN103223131B (en) | Liver disease drug | |
| CN102847061B (en) | Traditional Chinese medicine preparation for treating pediatric viral myocarditis and preparation method thereof | |
| CN102988851B (en) | Chinese medicine composition for treating hemoptysis and preparation method of Chinese medicine composition | |
| CN103071047B (en) | Decoction for treating silicosis and preparation method thereof | |
| CN101732652B (en) | Chinese patent medicament for treating ulcerative colitis | |
| CN103142920A (en) | Traditional Chinese medicine composition for treating hepatitis B and preparation method thereof | |
| CN102671056B (en) | Chinese medicinal composition for treating hepatitis and preparation method thereof | |
| CN107050352A (en) | A kind of Chinese medicine composition for treating chronic hepatitis B | |
| CN102302688B (en) | Traditional Chinese medicine used for treating influenza caused by damp toxin, and preparation method thereof | |
| CN101548993A (en) | Application of Japanese climbing fern spore in preparing lead excretion medicines or health products | |
| CN104096202B (en) | A kind of medicine for treating rotavirus enteritis and preparation method thereof | |
| CN105311602B (en) | A kind of Chinese medicine composition of prevention asthma in children | |
| CN104740405B (en) | A kind of Chinese medicine preparation and preparation method for treating anaphylactoid purpura renal damage | |
| CN117224624B (en) | Traditional Chinese medicine composition for preventing and/or treating renal edema and preparation method thereof | |
| CN108904746A (en) | A kind of Chinese medicine composition and its preparation method and application for treating ulcerative colitis | |
| CN118078942B (en) | Composition for treating obstructive sleep apnea-hypopnea syndrome, granule preparation and preparation method thereof | |
| CN103933189B (en) | One is treated uremic Chinese medicine preparation | |
| CN103656355B (en) | Medicine being used for the treatment of swine paratyphoid and preparation method thereof | |
| CN102233004B (en) | Drug for treating liver diseases | |
| CN1876062A (en) | Preparation method of traditional Chinese medicine for treating hepatitis B and liver cirrhosis and Chinese medicine prepared thereby | |
| CN104840574B (en) | A kind of Chinese medicine composition for treating hepatopathy and preparation method thereof | |
| CN105232609A (en) | Traditional Chinese medicine combination treating functional dyspepsia | |
| CN104127850A (en) | Traditional Chinese medicine preparation for treating infantile diarrhea |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| CB02 | Change of applicant information |
Address after: 400800 Chongqing Wansheng District Donglin Qingxi bridge Cao Jia Qiao Applicant after: Chongqing Duoputai Pharmaceutical Co., Ltd. Address before: 400800 Chongqing Qijiang district (formerly Wansheng District) Donglin Qingxi bridge Cao Jia Dian Applicant before: Chongqing Duoputai Pharmaceutical Co., Ltd. |
|
| CB02 | Change of applicant information | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20170818 |
|
| RJ01 | Rejection of invention patent application after publication |